LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 962 | 6712 | 10605 | 0.6329 | 0.5963 |
MCF 10A | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 962 | 9832 | 10605 | 0.9272 | 0.9199 |
MCF 10A | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9724 | 10605 | 0.9170 | 0.9087 |
MCF 10A | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 10735 | 10605 | 1.0123 | 1.0135 |
MCF 10A | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 962 | 9821 | 10605 | 0.9261 | 0.9188 |
MCF 10A | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 962 | 10510 | 10605 | 0.9911 | 0.9902 |
MCF 10A | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 962 | 10580 | 10605 | 0.9976 | 0.9974 |
MCF 10A | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10166 | 10605 | 0.9586 | 0.9545 |
MCF 10A | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 962 | 11286 | 10605 | 1.0642 | 1.0706 |
MCF 10A | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 10395 | 10605 | 0.9802 | 0.9782 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP5 | 72 | hr | 962 | 1047 | 10605 | 0.0987 | 0.0088 |
MCF 10A | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 962 | 1024 | 10605 | 0.0966 | 0.0064 |
MCF 10A | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 962 | 9561 | 10605 | 0.9016 | 0.8917 |
MCF 10A | Neratinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 3269 | 10605 | 0.3083 | 0.2392 |
MCF 10A | Nilotinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 9650 | 10605 | 0.9100 | 0.9010 |
MCF 10A | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 962 | 10709 | 10605 | 1.0099 | 1.0108 |
MCF 10A | NU7441 | 0.12 | uM | LJP5 | 72 | hr | 962 | 10592 | 10605 | 0.9988 | 0.9986 |
MCF 10A | Dactolisib | 0.12 | uM | LJP5 | 72 | hr | 962 | 1537 | 10605 | 0.1450 | 0.0596 |
MCF 10A | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 962 | 8136 | 10605 | 0.7672 | 0.7440 |
MCF 10A | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 962 | 5870 | 10605 | 0.5535 | 0.5090 |
MCF 10A | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 962 | 1928 | 10605 | 0.1818 | 0.1002 |
MCF 10A | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 962 | 1884 | 10605 | 0.1777 | 0.0956 |
MCF 10A | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 962 | 10757 | 10605 | 1.0144 | 1.0158 |
MCF 10A | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 962 | 4935 | 10605 | 0.4654 | 0.4121 |
MCF 10A | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 962 | 1400 | 10605 | 0.1321 | 0.0455 |